What's in Weight Loss Injections
Weight loss injections, often referred to as "jabs," have emerged as a popular option in the quest for shedding pounds. But what exactly are these injections, and how do they aid in weight loss? This article delves into the world of weight loss jabs, exploring their types, mechanisms, benefits, and potential drawbacks.
Weight loss injections, as the name suggests, are medications administered via injection to help with weight management. They work by targeting various hormonal and neurological pathways in the body, acting on appetite, metabolism, and fat storage. However, it's crucial to note that while these injections can be helpful, they're not a magic bullet. A balanced approach that combines these injections with a healthy diet and regular exercise is typically the most effective strategy.
Types of Weight Loss Injections
There are several types of weight loss injections, each with its unique mode of action:
- GLP-1 receptor agonists (e.g., Semaglutide, Liraglutide): These mimic natural hormones in your body to regulate appetite, insulin secretion, and glucose metabolism. They're often used for both type 2 diabetes management and weight loss.
Semaglutide (Wegovy, Ozempic, Rybelsus)
Semaglutide is a derivative of natural human GLP-1. It's available in both injectable and oral tablet forms (Rybelsus) and has shown promising results in clinical studies for weight loss, with some patients experiencing significant weight reduction.
One notable study, STEP 1 trials, showed that Semaglutide 2.4 mg led to an average weight loss of 15% from baseline versus 2.4% with placebo. However, it's important to note that these results were accompanied by side effects such as nausea, vomiting, and diarrhea.
Liraglutide (Saxenda, Victoza)
Liraglutide, another GLP-1 receptor agonist, is primarily used as an adjunct therapy for type 2 diabetes. However, some clinical trials have also explored its use for chronic weight management. In the Sweet Success trial, for instance, Liraglutide 3 mg led to an average weight loss of 8.0 kg (8.4%) versus 2.8 kg (3.2%) with placebo at one year.